Daphne Koller, formerly at Stanford University and cofounder of the online education company, Coursera, talks this week about using machine-learning to develop new drugs. Her approach is to use machine learning to accuratley identify cellular or genetic targets for treatment. The field is just getting started but promises to speed the development of new and better therapies to treat disease.